Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
Susanne Renz(University Hospital Southampton NHS Foundation Trust), Miriam Santer(NIHR Southampton Biomedical Research Centre), Matthew J Ridd(University of Bristol), Paul Little(University of Antwerp), Ingrid Müller(University of Southampton), Tracey Sach(University of East Anglia), Zina Eminton(University of Southampton), Irene Soulsby(University of Southampton), Fay Chinnery(University of Southampton), Alison Layton(University of York), Karen Thomas(University of Nottingham), Laura Day(University of Bedfordshire), Gareth Griffiths(NIHR Evaluation Trials and Studies Coordinating Centre), Louise Stanton(University of Southampton), Beth Stuart(Queen Mary University of London), Nick Francis(University of Oxford), Jacqui Nuttall(University of Southampton), Kim S Thomas(University of Nottingham)
Cited by 17
Related Papers
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group
|Journal of the American Academy of Dermatology|2009|835
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
|The Lancet|2007|570
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
|The Lancet Oncology|2018|501